Fu Peng
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Natural product bioactivities and synthesis 5
- Circular RNAs in diseases 4
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 8
- Co-authors
- Cheng Peng (25 shared papers)Lei Yu (3 shared papers)Hailin Tang (8 shared papers)Xiaofang Xie (10 shared papers)Jianping Chen (1 shared paper)Qingqing Liu (1 shared paper)Yan Chen (5 shared papers)Gangmin Li (5 shared papers)
In The Last Decade
Fu Peng
52 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 253
- Pharmacology 138
- Complementary and alternative medicine 82
- Molecular Biology 682
- Biochemistry 52
Countries citing papers authored by Fu Peng
This map shows the geographic impact of Fu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Peng more than expected).
Fields of papers citing papers by Fu Peng
This network shows the impact of papers produced by Fu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Peng. The network helps show where Fu Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 144 | |
| 2 | 2021 | 103 | |
| 3 | 2022 | 97 | |
| 4 | 2019 | 87 | |
| 5 | 2021 | 81 | |
| 6 | 2018 | 73 | |
| 7 | 2021 | 64 | |
| 8 | 2022 | 58 | |
| 9 | 2015 | 50 | |
| 10 | 2021 | 48 | |
| 11 | 2023 | 47 | |
| 12 | 2023 | 45 | |
| 13 | 2020 | 44 | |
| 14 | 2019 | 34 | |
| 15 | 2021 | 29 | |
| 16 | 2019 | 29 | |
| 17 | 2021 | 29 | |
| 18 | 2022 | 28 | |
| 19 | 2022 | 24 | |
| 20 | 2021 | 24 |
About Fu Peng
Fu Peng is a scholar working on Molecular Biology, Cancer Research, Oncology, Pharmacology and Food Science, having authored 59 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers), Natural product bioactivities and synthesis (5 papers), Essential Oils and Antimicrobial Activity (5 papers), Cancer Mechanisms and Therapy (4 papers), Circular RNAs in diseases (4 papers), Cancer Cells and Metastasis (3 papers) and Plant-based Medicinal Research (3 papers). The work is most often cited by research in Cancer Research (253 citations), Pharmacology (138 citations), Complementary and alternative medicine (82 citations), Molecular Biology (682 citations) and Biochemistry (52 citations). Fu Peng has collaborated with scholars based in China, Macao and Hong Kong. Frequent co-authors include Cheng Peng, Lei Yu, Hailin Tang, Xiaofang Xie, Jianping Chen, Qingqing Liu, Yan Chen, Gangmin Li, Junren Chen and Liang Xiong. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Ethnopharmacology, The American Journal of Chinese Medicine, Phytotherapy Research and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.